DocDollars

Ars Pharmaceuticals Operations, Inc.

CA · United States · Reporting entity ID 100001454067

Total reported 2019–2025
$2.24M
#987 of 2,960 reporting companies — 0% of all reported industry payments
$2.10M in general payments across 23,693 records, plus $144K in research funding across 24 records.

How it breaks down

General payments $2,097,895
Research funding $144,169

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ars Pharmaceuticals Operations, Inc. reported $2.24M to US doctors and teaching hospitals from 2019 to 2025, ranking #987 of 2,960 reporting companies. 6% of that was research funding and 94% general payments such as consulting, speaking, food and travel. 23,693 general payment records and 24 research records were filed.

Common questions about Ars Pharmaceuticals Operations, Inc.

How much has Ars Pharmaceuticals Operations, Inc. paid US doctors?

Ars Pharmaceuticals Operations, Inc. reported $2,242,064 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,097,895 in general payments, $144,169 in research funding.

How does Ars Pharmaceuticals Operations, Inc. rank among drug and device companies?

It ranks #987 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ars Pharmaceuticals Operations, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.